Multiple Assemblies exist for SMTL entry 5sfj
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c2(c(C(=O)NCc1ncccc1)cnn2C)C(=O)Nc4nc3nc(cn3cc4)c5ccccc5, micromolar IC50=0.0118605; X-RAY DIFFRACTION 2.41 Å

	SMTL ID 5sfj.1 Ligands ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4R)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(pyridin-2-yl)methyl]-1H-pyrazole-4,5-dicarboxamide Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sfj.2 Ligands ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4R)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(pyridin-2-yl)methyl]-1H-pyrazole-4,5-dicarboxamide Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sfj.3 Ligands ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4R)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(pyridin-2-yl)methyl]-1H-pyrazole-4,5-dicarboxamide Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sfj.4 Ligands ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4R)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(pyridin-2-yl)methyl]-1H-pyrazole-4,5-dicarboxamide Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer